This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bayry J, Negi VS, Kaveri SV . Intravenous immunoglobulin therapy in rheumatic diseases. Nat Rev Rheumatol 2011; 7: 349–359.
Seite JF, Shoenfeld Y, Youinou P, Hillion S . What is the contents of the magic draft IVIg? Autoimmun Rev 2008; 7: 435–439.
Schwab I, Nimmerjahn F . Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol 2013; 13: 176–189.
Kessel A, Ammuri H, Peri R, Pavlotzky ER, Blank M, Shoenfeld Y et al. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol 2007; 179: 5571–5575.
Massoud AH, Yona M, Xue D, Chouiali F, Alturaihi H, Ablona A et al. Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells. J Allergy Clin Immunol 2014; 133: 853–863.e855.
Bayry J, Mouthon L, Kaveri SV . Intravenous immunoglobulin expands regulatory T cells in autoimmune rheumatic disease. J Rheumatol 2012; 39: 450–451.
Tsurikisawa N, Saito H, Oshikata C, Tsuburai T, Akiyama K . High-dose intravenous immunoglobulin treatment increases regulatory T cells in patients with eosinophilic granulomatosis with polyangiitis. J Rheumatol 2012; 39: 1019–1025.
Trinath J, Hegde P, Sharma M, Maddur MS, Rabin M, Vallat JM et al. Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells. Blood 2013; 122: 1419–1427.
Wiedeman AE, Santer DM, Yan W, Miescher S, Kasermann F, Elkon KB . Contrasting mechanisms of interferon-alpha inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists. Arthritis Rheum 2013; 65: 2713–2723.
Kalinski P . Regulation of immune responses by prostaglandin E2. J Immunol 2012; 188: 21–28.
Acknowledgements
This work was supported by the Institut National de la Santé et de la Recherche Médicale, Université Pierre et Marie Curie, Université Paris Descartes (SVK and JB); the Centre National de la Recherche Scientifique (SVK), the European Community's Seventh Framework Programme [FP7/2007–2013] under grant agreement 260338 ALLFUN (JB); the Indian Institute of Science, the Department of Biotechnology, the Department of Science and Technology, Council for Scientific and Industrial Research (KNB); Coopération INSERM-ICMR-AO 2009/2010 (KNB and JB) and fellowships from INSERM-ICMR, the Council for Scientific and Industrial Research (JT) and Journées de Neurologie de Langue Française (MR).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
This work is partially supported by financial support from CSL Behring, France.
Rights and permissions
About this article
Cite this article
Maddur, M., Trinath, J., Rabin, M. et al. Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with increased prostaglandin E2 levels in the circulation. Cell Mol Immunol 12, 650–652 (2015). https://doi.org/10.1038/cmi.2014.117
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2014.117
This article is cited by
-
Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis
Clinical Reviews in Allergy & Immunology (2020)
-
Novel pathomechanisms in inflammatory neuropathies
Journal of Neuroinflammation (2017)
-
Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy
Journal of Neuroinflammation (2017)
-
Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin
Scientific Reports (2016)
-
Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patients
Immunologic Research (2014)